Hospitalizations for vaccine preventable pneumonias in patients with inflammatory bowel disease: A 6-year analysis of the Nationwide Inpatient Sample

Clinical and Experimental Gastroenterology

Volumn 6, Issue 1, 2013, Pages 43-49

  Stobaugh, Derrick J ^a   Deepak, Parakkal ^a   Ehrenpreis, Eli D ^a  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

Colitis; Crohn's disease; Infection; Pneumonia; Ulcerative; Vaccination

Indexed keywords

ADULT; ARTICLE; BACTERIAL PNEUMONIA; BACTERIUM IDENTIFICATION; CAUSE OF DEATH; CONTROLLED STUDY; CROHN DISEASE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; FEMALE; HAEMOPHILUS INFLUENZAE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFLUENZA VACCINATION; INFLUENZA VIRUS; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; NONHUMAN; STREPTOCOCCUS PNEUMONIA; TREND STUDY; ULCERATIVE COLITIS; VIRUS IDENTIFICATION; VIRUS PNEUMONIA;

EID: 84877609489     PISSN: None     EISSN: 11787023     Source Type: Journal    
DOI: 10.2147/CEG.S42514     Document Type: Article

References (30)

1. Heatley RV, Thomas P, Prokipchuk EJ, Gauldie J, Sieniewicz DJ, Bienenstock J. Pulmonary function abnormalities in patients with inflammatory bowel disease. Q J Med. 1982;51:241-250.
2. Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology. 2005;129(3):827-836.
3. Storch I, Sachar D, Katz S. Pulmonary manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2003;9(2):104-115.
4. Duricova D, Pedersen N, Elkjaer M, Gamborg M, Munkholm P, Jess T. Overall and cause specific mortality in Crohn's disease: a meta-analysis of population-based studies. Inflamm Bowel Dis. 2010;16(2): 347-353.
5. Jess T, Gamborg M, Munkholm P, Sørensen TI. Overall and cause-specific mortality in ulcerative colitis: meta-analysis of population-based inception cohort studies. Am J Gastroenterol. 2007;102(3):609-617.
6. Black H, Mendoza M, Murin S. Thoracic manifestations of inflammatory bowel disease. Chest. 2007;131(2):524-532.
7. Long MD, Martin C, Sandler RS, Kappelman MD. Increased risk of pneumonia among patients with inflammatory bowel disease. Am J Gastroenterol. 2013;108:240-248. Epub January 8, 2013.
8. Colombel JF, Loftus EV Jr, Tremaine WJ, et al. The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients. Gastroenterology. 2004;126:19-31.
9. Grijalva CG, Chen L, Delzell E, et al. Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases. JAMA. 2011;306:2331-2339.
10. Rahier JF, Ben-Horin S, Chowers Y, et al. European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis. 2009;3: 47-91.
11. Sands BE, Cuffari C, Katz J, et al. Guidelines for immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2004;10: 677-692.
12. Steinhart R, Reingold AL, Taylor F, Anderson G, Wenger JD. Invasive Haemophilus influenzae infections in men with HIV infection. JAMA. 1992;268:3350-3352.
13. Melmed GY, Ippoliti AF, Papadakis KA, et al. Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses. Am J Gastroenterol. 2006;101:1834-1840.
14. Healthcare Cost and Utilization Project (HCUP). HCUP NIS Database Documentation. 2012 Agency for Healthcare Research and Quality, Rockville, MD. Available from: http://www.hcup-us.ahrq.gov/. Accessed June 8, 2012.
15. World Health Organization. Internatinal classification of diseases. [Webpage on the Internet]. http://www.who.int/classifications/icd/en/index.html. Accessed March 26, 2013.
16. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36:8-27.
17. AHRQ and a Federal-State-Industry partnership. Comorbidity. 2012 Agency for Healthcare Research and Quality, Rockville, MD. Available from: http://www.hcup-us.ahrq.gov/. Accessed June 27, 2012.
18. Schafer JL. Multiple imputation: a primer. Stat Methods Med Res. 1999;8:3-15.
19. Armstrong K, Berlin M, Schwartz JS, Propert K, Ubel PA. Barriers to influenza immunization in a low-income urban population. Am J Prev Med. 2001;20:21-25.
20. Viget N, Vernier-Massouille G, Salmon-Ceron D, Yazdanpanah Y, Colombel JF. Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis. Gut. 2008;57:549-558.
21. Toruner M, Loftus EV Jr, Hamrsen WS, Zinsmeister AR, Orenstein R, Sandborn WJ, et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology. 2008;134: 929-936.
22. Farah R, Lisitsin S, Shay M. Bacterial meningitis associated with infliximab. Pharm World Sci. 2006;28:123-125.
23. van der Poll T, Keogh CV, Buurman WA, Lowry SF. Passive immunization against tumor necrosis factor-alpha impairs host defense during pneumococcal pneumonia in mice. Am J Respir Crit Care Med. 1997;155:603-608.
24. Vila-Corcoles A, Ochoa-Gondar O, Rodriguez-Blanco T, Raga-Luria X, Gomez-Bertomeu F; EPIVAC Study Group. Epidemiology of community-acquired pneumonia in older adults: a population-based study. Respir Med. 2009;103(2):309-316.
25. Bisgard KM, Kao A, Leake J, Strebel PM, Perkins BA, Wharton M. Haemophilus influenzae invasive disease in the United States, 1994-1995: near disappearance of a vaccine-preventable childhood disease. Emerg Infect Dis. 1998;4:229-237.
26. Centers for Disease Control and Prevention. Recommended adult immunization schedule-United States, 2012. J Midwifery Womens Health. 2012;57:188-195.
27. Melmed GY. Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics. Inflamm Bowel Dis. 2009;15:1410-1416.
28. Van Assen S, Elkayam O, Agmon-Levin N, et al. Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases. Autoimmun Rev. 2011;10:341-352.
29. Fiorino G, Peyrin-Biroulet L, Naccarato P, et al. Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study. Inflamm Bowel Dis. 2012;18(6):1042-1047. Epub June 14, 2011.
30. Simborg DW. DRG creep: a new hospital-acquired disease. N Engl J Med. 1981;304:1602-1604.